Philip Mease and et.al.. "FRI0512 APREMILAST, AN ORAL PHOSPHODIESTERASE 4 INHIBITOR, IS ASSOCIATED WITH LONG-TERM (156-WEEK) IMPROVEMENTS IN BASDAI IN PSORIATIC ARTHRITIS PATIENTS: POOLED RESULTS FROM 3 PHASE III, RANDOMIZED, CONTROLLED TRIALS. The European League against Rheumatism (EULAR) Annual European Congress of Rheumatology, Madrid, June 2017." The European League against Rheumatism (EULAR) Annual European Congress of Rheumatology (2017)
Available at: http://works.bepress.com/philip-mease/250/